Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - The Lancet …, 2012 - thelancet.com
Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …
被引用次数：374 相关文章

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - Lancet Neurology …, 2012 - pure.au.dk
In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban
compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and previous …

[引用][C] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, CB Granger, JH Alexander… - The Lancet …, 2012 - elibrary.ru
[PDF] redheracles.net

[PDF][PDF] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - Lancet …, 2012 - redheracles.net
Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - Lancet …, 2012 - swepub.kb.se
BackgroundIn the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …

[引用][C] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - LANCET …, 2012 - arpi.unipi.it
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or
transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial IRIS IRIS Home Sfoglia …

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit… - The lancet neurology …, 2012 - repository.uantwerpen.be
Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, R Lopes, M Bahit… - Lancet …, 2012 - researchnow.flinders.edu.au
Background: In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - The Lancet …, 2012 - Elsevier
BACKGROUND: In the ARISTOTLE trial, the rate of stroke or systemic embolism was
reduced by apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients …

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

JD Easton, RD Lopes, MC Bahit, DM Wojdyla… - The Lancet …, 2012 - dial.uclouvain.be
BACKGROUND: In the ARISTOTLE trial, the rate of stroke or systemic embolism was
reduced by apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients …